Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients

Journal of Clinical Gastroenterology

Volumn 43, Issue 6, 2009, Pages 580-585

  Boursier, Jérôme ^a   Cesbron, Elodie ^b   Tropet, Anne Laure ^b   Pilette, Christophe ^b,c  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b CENTRE HOSPITALIER DU MANS   (France)

^c Centre Hospitalier du Mans   (France)

Author keywords

Child Pugh score; Cirrhosis; MELD; Mortality; Prognostic

Indexed keywords

BILIRUBIN; PROTHROMBIN; SERUM ALBUMIN; SODIUM;

ADULT; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; CHILD PUGH SCORE; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SODIUM BLOOD LEVEL;

AGED; FEMALE; GASTROENTEROLOGY; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SODIUM; SURVIVAL RATE;

EID: 67651083374     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181889468     Document Type: Article

References (25)

1. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864-871. (Pubitemid 30169932)
2. Kamath PS, Wiesner RH, MalinchocM, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33:464-470. (Pubitemid 32119037)
3. Freeman RB, Wiesner RH, Edwards E, et al. Results of the first year of the new liver allocation plan. Liver Transplant. 2004;10:7-15. (Pubitemid 38885887)
4. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42(suppl): S100-S107. (Pubitemid 40364609)
5. Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut. 2003;52:134-139. (Pubitemid 36020780)
6. Degre D, Bourgeois N, Boon N, et al. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transplant Int. 2004;17:31-38. (Pubitemid 38197024)
7. Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40:802-810. (Pubitemid 39288112)
8. Biggins SW, Rodriguez HJ, Bacchetti P, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005;41:32-39. (Pubitemid 40066380)
9. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652-1660. (Pubitemid 43668830)
10. Korner T, Kropf J, Kosche B, et al. Improvement of prognostic power of the Child-Pugh classification of liver cirrhosis by hyaluronan. J Hepatol. 2003;39:947-953. (Pubitemid 37523764)
11. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845.
12. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7: 122-128. (Pubitemid 17019862)
13. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231. (Pubitemid 41772537)
14. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91-96. (Pubitemid 36055342)
15. Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transplant. 2002;8:851-858. (Pubitemid 35012300)
16. Angermayr B, Cejna M, Karnel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003;52: 879-885. (Pubitemid 36613497)
17. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol. 2004;40:897-903. (Pubitemid 38670122)
18. Gines P, Cardenas A, Arroyo V, et al. Management of cirrhosis and ascites. N Engl J Med. 2004;350:1646-1654.
19. Salerno F, Gerbes A, Gines P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007; 56:1310-1318. (Pubitemid 47300435)
20. Korner T, Kropf J, Gressner AM. Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol. 1996;25:684-688. (Pubitemid 26373886)
21. Denson KW, Reed SV, Haddon ME. Validity of the INR system for patients with liver impairment. Thromb Haemost. 1995;73:162.
22. Kovacs MJ, Wong A, MacKinnon K, et al. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost. 1994;71:727-730. (Pubitemid 24177960)
23. Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology. 1996;24:1392-1394.
24. Bellest L, Eschwege V, Poupon R, et al. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology. 2007;46:528-534. (Pubitemid 47344789)
25. Tripodi A, Chantarangkul V, Primignani M, et al. The international normalized ratio calibrated for cirrhosis [INR (liver)] normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology. 2007;46: 520-527. (Pubitemid 47344788)